FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2019551686> ?p ?o ?g. }

• W2019551686 endingPage "S222" @default.
• W2019551686 startingPage "S217" @default.
• W2019551686 abstract "Based on the results of the U.K. Prospective Diabetes Study (UKPDS), “… treatment of type 2 diabetes [should] include aggressive efforts to lower blood glucose levels as close to normal as possible. …” This was the recommendation the American Diabetes Association promulgated based on the results of the UKPDS when published (1). The suggestion was soon adopted by official guidelines in every region of the world (2). They are generally consistent in recommending an A1C goal of <7.0%. However, the results of the UKPDS remained inconclusive with respect to cardiovascular (CV) complications because of a risk reduction that was only close to statistical significance (−16%, P = 0.052). In support of the UKPDS results, however, a recent meta-analysis of randomized trials in type 2 diabetes (3) calculated a 19% reduction in the incidence of any type of macrovascular event associated with improved long-term glycemic control. Moreover, a strong association between glycemic control and micro- and macrovascular disease has been highlighted in type 1 diabetic patients (4,5).Nevertheless, these results have been challenged by recent large-scale intervention trials. The Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial randomized >10,000 subjects with type 2 diabetes and vascular disease, or multiple CV risk factors, to an intensive treatment program targeting normal blood glucose values and A1C <6%, or a standard treatment program aiming at A1C between 7 and 7.9%. The intensive blood glucose arm was prematurely stopped because of excess mortality (hazard ratio [HR] 1.22, 95% CI 1.01–1.46; P = 0.04) and lack of significant reduction of primary outcome, i.e., a composite of nonfatal myocardial infarction, nonfatal stroke, or death from CV causes (HR 0.90, 0.78–1.04; P = 0.16) (6). After a median 5-year follow-up, the Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation (ADVANCE), …" @default.
• W2019551686 created "2016-06-24" @default.
• W2019551686 creator A5002097782 @default.
• W2019551686 creator A5019711625 @default.
• W2019551686 creator A5070377136 @default.
• W2019551686 date "2009-11-01" @default.
• W2019551686 modified "2023-09-24" @default.
• W2019551686 title "Changing the Treatment Paradigm for Type 2 Diabetes" @default.
• W2019551686 cites W1526927233 @default.
• W2019551686 cites W1554005703 @default.
• W2019551686 cites W172609984 @default.
• W2019551686 cites W1752045965 @default.
• W2019551686 cites W1970710636 @default.
• W2019551686 cites W1972329806 @default.
• W2019551686 cites W1975588287 @default.
• W2019551686 cites W1985246220 @default.
• W2019551686 cites W1995404454 @default.
• W2019551686 cites W2005039844 @default.
• W2019551686 cites W2027998675 @default.
• W2019551686 cites W2029084557 @default.
• W2019551686 cites W2029458191 @default.
• W2019551686 cites W2035226712 @default.
• W2019551686 cites W2048376525 @default.
• W2019551686 cites W2048565142 @default.
• W2019551686 cites W2070292895 @default.
• W2019551686 cites W2080594601 @default.
• W2019551686 cites W2081276121 @default.
• W2019551686 cites W2089770071 @default.
• W2019551686 cites W2093644864 @default.
• W2019551686 cites W2096691922 @default.
• W2019551686 cites W2097112828 @default.
• W2019551686 cites W2101725562 @default.
• W2019551686 cites W2101766292 @default.
• W2019551686 cites W2109728760 @default.
• W2019551686 cites W2113322194 @default.
• W2019551686 cites W2124701241 @default.
• W2019551686 cites W2133538728 @default.
• W2019551686 cites W2139611060 @default.
• W2019551686 cites W2139634859 @default.
• W2019551686 cites W2141713511 @default.
• W2019551686 cites W2156462071 @default.
• W2019551686 cites W2158666727 @default.
• W2019551686 cites W2158822657 @default.
• W2019551686 cites W2159205789 @default.
• W2019551686 cites W2167000598 @default.
• W2019551686 cites W2169715407 @default.
• W2019551686 cites W2170271198 @default.
• W2019551686 cites W2332951586 @default.
• W2019551686 cites W2337454357 @default.
• W2019551686 cites W2529057497 @default.
• W2019551686 cites W2769264260 @default.
• W2019551686 cites W4250647894 @default.
• W2019551686 cites W95698275 @default.
• W2019551686 doi "https://doi.org/10.2337/dc09-s314" @default.
• W2019551686 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2811445" @default.
• W2019551686 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19875555" @default.
• W2019551686 hasPublicationYear "2009" @default.
• W2019551686 type Work @default.
• W2019551686 sameAs 2019551686 @default.
• W2019551686 citedByCount "35" @default.
• W2019551686 countsByYear W20195516862012 @default.
• W2019551686 countsByYear W20195516862013 @default.
• W2019551686 countsByYear W20195516862014 @default.
• W2019551686 countsByYear W20195516862015 @default.
• W2019551686 countsByYear W20195516862016 @default.
• W2019551686 countsByYear W20195516862017 @default.
• W2019551686 countsByYear W20195516862018 @default.
• W2019551686 countsByYear W20195516862020 @default.
• W2019551686 countsByYear W20195516862021 @default.
• W2019551686 countsByYear W20195516862022 @default.
• W2019551686 crossrefType "journal-article" @default.
• W2019551686 hasAuthorship W2019551686A5002097782 @default.
• W2019551686 hasAuthorship W2019551686A5019711625 @default.
• W2019551686 hasAuthorship W2019551686A5070377136 @default.
• W2019551686 hasBestOaLocation W20195516861 @default.
• W2019551686 hasConcept C134018914 @default.
• W2019551686 hasConcept C17744445 @default.
• W2019551686 hasConcept C177713679 @default.
• W2019551686 hasConcept C199539241 @default.
• W2019551686 hasConcept C2777180221 @default.
• W2019551686 hasConcept C2779473830 @default.
• W2019551686 hasConcept C3018376624 @default.
• W2019551686 hasConcept C555293320 @default.
• W2019551686 hasConcept C71924100 @default.
• W2019551686 hasConceptScore W2019551686C134018914 @default.
• W2019551686 hasConceptScore W2019551686C17744445 @default.
• W2019551686 hasConceptScore W2019551686C177713679 @default.
• W2019551686 hasConceptScore W2019551686C199539241 @default.
• W2019551686 hasConceptScore W2019551686C2777180221 @default.
• W2019551686 hasConceptScore W2019551686C2779473830 @default.
• W2019551686 hasConceptScore W2019551686C3018376624 @default.
• W2019551686 hasConceptScore W2019551686C555293320 @default.
• W2019551686 hasConceptScore W2019551686C71924100 @default.
• W2019551686 hasIssue "suppl_2" @default.
• W2019551686 hasLocation W20195516861 @default.
• W2019551686 hasLocation W20195516862 @default.
• W2019551686 hasLocation W20195516863 @default.
• W2019551686 hasLocation W20195516864 @default.

• next